Logo image
Gonorrhea and Chlamydia Testing Increasing but Still Lagging in HIV Clinics in the United States
Journal article   Open access   Peer reviewed

Gonorrhea and Chlamydia Testing Increasing but Still Lagging in HIV Clinics in the United States

Stephen A. Berry, Khalil G. Ghanem, William Christopher Mathews, Philip Todd Korthuis, Baligh R. Yehia, Allison L. Agwu, Christoph U. Lehmann, Richard D. Moore, Sara L. Allen, Kelly A. Gebo, …
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, v 70(3)
01 Nov 2015
PMID: 26068721
url
https://europepmc.org/articles/pmc4607588View

Abstract

Immunology Infectious Diseases Life Sciences & Biomedicine Science & Technology
Screening persons living with HIV for gonorrhea and chlamydia has been recommended since 2003. We compared annual gonorrhea/chlamydia testing to syphilis and lipid testing among 19,368 adults (41% men who have sex with men, 30% heterosexual men, and 29% women) engaged in HIV care. In 2004, 22%, 62%, and 70% of all patients were tested for gonorrhea/chlamydia, syphilis, and lipid levels, respectively. Despite increasing steadily [odds ratio per year (95% confidence interval): 1.14 (1.13 to 1.15)], gonorrhea/chlamydia testing in 2010 remained lower than syphilis and lipid testing (39%, 77%, 76%, respectively). Interventions to improve gonorrhea/chlamydia screening are needed. A more targeted screening approach may be warranted.

Metrics

8 Record Views
17 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Immunology
Infectious Diseases
Logo image